6533b821fe1ef96bd127c458
RESEARCH PRODUCT
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Manuel DelgadoMar LozanoAlejandro FornerBruno SangroAlessandro GranitoMargarita SalaMonica RonzoniGiuseppe CabibboFrederik J H HoogwaterJosé Luis LledóRosanna VillaniAlessandra ElveviLorenza RimassaJuan AcevedoMariona CalvoMercedes VergaraMercedes VergaraSergio Muñoz-martínezJean-charles NaultJuan C. BandiMarkus Peck-radosavljevicBrandon M. MeyersMarco Sanduzzi-zamparelliRogerio AlvesSaleh A. AlqahtaniAlberto E. MuñozSonia PascualAlberto LuéJosepmaria ArgemiBeatriz MinguezHenning WegeGiovan Giuseppe Di CostanzoDavid J. PinatoVictor SapenaMaria GuarinoStefano OkolicsanyiVivianne MelloMartina GambatoSusanna CollCarlos BenítezDhanny GomezChristoph RoderburgPeter R. GalleBristi BasuBristi BasuFederico PiñeroCassia LealFrank TackeChristie PerellóTudor MocanMassimiliano SalatiHelen L. ReevesJörg TrojanVincenzo CardinaleMohamed El KassasTom LüddeJohn BridgewaterMário Reis ÁLvares-da-silvaAnja LachenmayerGiovanni BrandiAlex Vianey Callado FrançaMohamed BouattourTim MeyerGerda Elisabeth VilladsenM. VarelaJordi BruixDalia Morales-arraezCarlos Rodríguez-lopeChristian TosoWacław HołówkoPhilippe MerleManuel Romero‐gomezIgnacio García-juárezFernanda BrancoGonzalo SapisochinChiara BraconiEmmanouil GiorgakisHidenori ToyodaLorraine BlaiseAna María Matilla PeñaAndrea Casadei‐gardiniLeonardo G Da FonsecaAlexander SiebenhünerMaria ReigGustavo PereiraMassimo IavaroneMaria Margarita Anderssubject
Hepatocellular carcinomaLCmedicine.medical_treatment:diagnóstico::toma de decisiones clínicas [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]NursesRC799-869Liver transplantationCholangiocarcinomaClinical trialsENS-CCAInterquartile rangeDecisió Presa dePandemic:Other subheadings::/diagnosis [Other subheadings]:virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]CERO-19Pandèmia de COVID-19 2020-Immunology and AllergyiCCA intrahepatic cholangiocarcinomaCOVID-19 coronavirus disease 2019Liver Cancer Outcome in the COVID-19-pandemic ProjectSettore MED/12 - Gastroenterologiaddc:617IQRGastroenterologyBCLC Barcelona Clinic Liver Cancer:Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]:neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias hepáticas [ENFERMEDADES]Diseases of the digestive system. GastroenterologyManagementClinical PracticeClinical trialEuropean Network for the Study of Cholangiocarcinoma:Diagnosis::Clinical Decision-Making [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]Fetge - Malalties - DiagnòsticInterquartile rangeLiver cancerLiver cancerPROGRESSION-FREE SURVIVALLiver Cancermedicine.medical_specialtyCoronavirus disease 2019 (COVID-19):Otros calificadores::/diagnóstico [Otros calificadores]610 Medicine & health:Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Liver Neoplasms [DISEASES]LT liver transplantationArticleBarcelona Clinic Liver CancerInternal MedicinemedicineENS-CCA European Network for the Study of CholangiocarcinomaHepatologybusiness.industryCERO-19 Liver Cancer Outcome in the COVID-19-pandemic ProjectCOVID-19IQR Interquartile rangemedicine.diseaseBCLCClinical trialEmergency medicineObservational study610 Medizin und GesundheitbusinessHCC hepatocellular carcinomaLC liver cancerSARS-CoV-2 severe acute respiratory syndrome coronavirus-2description
[Background & Aims] The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed because of the COVID-19 pandemic.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-06-01 |